Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
27.7%
% of IDNA's 51 holdings also in SBIO
15.1%
% of SBIO's 87 holdings also in IDNA
Overlap by Weight
Sector Drift (IDNA minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IDNA |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 5.6% | 3.1% | 3.1% |
|
ARCELLX, INC. | 2.5% | 2.3% | 2.3% |
|
SPRINGWORKS THERAPEUTICS, INC. | 2.6% | 2.3% | 2.3% |
|
GERON CORP | 2.3% | 1.1% | 1.1% |
|
4D MOLECULAR THERAPEUTICS, INC. | 1.2% | 1.1% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
IDNA Overweight Relative to SBIO
|
SAREPTA THERAPEUTICS INC | 5.3% |
|
MODERNA, INC. | 5.0% |
|
MERCK & CO. INC. | 4.7% |
|
REGENERON PHARMACEUTICALS | 4.3% |
|
EXELIXIS INC | 4.0% |
 |
SANOFI-AVENTIS | 3.9% |
|
INCYTE CORP | 3.8% |
 |
TAKEDA PHARMACEUTICAL CO LTD | 3.6% |
 |
GENMAB A/S | 3.6% |
 |
ROCHE HOLDING LTD | 3.5% |
IDNA Underweight Relative to SBIO
|
VIKING THERAPEUTICS, INC. | -5.3% |
|
CEREVEL THERAPEUTICS HOLDINGS INC | -4.8% |
|
VAXCYTE, INC. | -4.6% |
 |
ALKERMES PLC | -2.8% |
|
AXSOME THERAPEUTICS, INC. | -2.3% |
|
CRINETICS PHARMACEUTICALS INC | -2.1% |
|
XENON PHARMACEUTICALS INC. | -2.0% |
|
IDEAYA BIOSCIENCES, INC. | -2.0% |
 |
IMMUNOCORE HOLDINGS PLC SPONSORED AD | -1.9% |
|
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -1.9% |